459 related articles for article (PubMed ID: 28301994)
21. Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study.
Stampfl U; Bermejo JL; Sommer CM; Hoffmann K; Weiss KH; Schirmacher P; Schemmer P; Kauczor HU; Richter GM; Radeleff BA; Longerich T
J Vasc Interv Radiol; 2014 Jul; 25(7):1018-1026.e4. PubMed ID: 24768235
[TBL] [Abstract][Full Text] [Related]
22. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta-analysis.
Si T; Chen Y; Ma D; Gong X; Guan R; Shen B; Peng C
J Gastroenterol Hepatol; 2017 Jul; 32(7):1286-1294. PubMed ID: 28085213
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
24. Hepatic artery thrombosis after orthotopic liver transplant: a review of the same institute 5 years later.
Wu L; Zhang J; Guo Z; Tai Q; He X; Ju W; Wang D; Zhu X; Ma Y; Wang G; Hu A
Exp Clin Transplant; 2011 Jun; 9(3):191-6. PubMed ID: 21649568
[TBL] [Abstract][Full Text] [Related]
25. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
26. Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation.
Yamagami T; Yoshimatsu R; Ishikawa M; Kajiwara K; Aikata H; Tashiro H; Kakizawa H; Toyoda N; Ohdan H; Awai K
Hepatogastroenterology; 2014; 61(133):1387-92. PubMed ID: 25436316
[TBL] [Abstract][Full Text] [Related]
27. Drug-Eluting Bead Transarterial Chemoembolization as Bridge Therapy for Hepatocellular Carcinoma Before Living-Donor Liver Transplantation.
Yu CY; Ou HY; Weng CC; Huang TL; Chen TY; Leung-Chit L; Hsu HW; Chen CL; Cheng YF
Transplant Proc; 2016 May; 48(4):1045-8. PubMed ID: 27320552
[TBL] [Abstract][Full Text] [Related]
28. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment.
Lima M; Dutra S; Gomes FV; Bilhim T; Coimbra É
Acta Med Port; 2018 Jan; 31(1):22-29. PubMed ID: 29573765
[TBL] [Abstract][Full Text] [Related]
30. Imaging Validation of Drug-Eluting Beads Transarterial Chemoembolization of Hepatocellular Carcinomas in Living Donor Liver Transplantation.
Tong YS; Huang TL; Chen TY; Tsang LLC; Ou HY; Yu CY; Hsu HW; Xiong LW; Liao CC; Eng HL; Chen CL; Cheng YF
Transplant Proc; 2018 Nov; 50(9):2622-2625. PubMed ID: 30401362
[TBL] [Abstract][Full Text] [Related]
31. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
33. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
[TBL] [Abstract][Full Text] [Related]
34. Safety and feasibility of same-day discharge of patients with hepatocellular carcinoma treated with transarterial chemoembolization with drug-eluting beads in a liver transplantation program.
Nasser F; Cavalcante RN; Galastri FL; de Rezende MB; Felga GG; Travassos FB; De Fina B; Affonso BB
J Vasc Interv Radiol; 2014 Jul; 25(7):1012-7. PubMed ID: 24704346
[TBL] [Abstract][Full Text] [Related]
35. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series.
Rose SC; Narsinh KH; Newton IG
J Vasc Interv Radiol; 2017 Jan; 28(1):103-110. PubMed ID: 27840042
[TBL] [Abstract][Full Text] [Related]
36. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
38. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
39. Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinoma.
Radunz S; Saner FH; Treckmann J; Rekowski J; Theysohn JM; Müller S; Best J; Sotiropoulos GC; Paul A; Benkö T
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28836737
[TBL] [Abstract][Full Text] [Related]
40. Prior Trans-arterial chemoembolization - A protective factor against rapid HCV recurrence post liver transplant in patients with HCV with HCC? - A Retrospective Cohort Study.
Vasavada B
Int J Surg; 2016 Jun; 30():132-5. PubMed ID: 27154618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
